These two targets have a few interacting proteins in common such as TIMP (1, 2 and 3), STAT 3, VEGF A, SRC, DCN, MMP 10 and CD 44 (Fig. S8) and all are supposed to be plum targets for cancer therapies. This evidence concerns the gene SRC and cancer.